Enucleation: Is wrapping the implant necessary for optimal motility?

Ophthalmic Plastic and Reconstructive Surgery

Volumn 19, Issue 3, 2003, Pages 194-197

  Long, John A ^a,b   Tann III, Thomas M ^a   Bearden III, William H ^a   Callahan, Michael A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; HYDROXYAPATITE;

ADULT; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DONOR; ENUCLEATION; EXTRAOCULAR MUSCLE; EYE MOVEMENT CONTROL; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; MATERIAL COATING; OBSERVATION; ORBIT IMPLANT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TECHNIQUE; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

COATED MATERIALS, BIOCOMPATIBLE; DURAPATITE; EYE ENUCLEATION; EYE MOVEMENTS; FIXATION, OCULAR; HUMANS; OCULOMOTOR MUSCLES; ORBITAL IMPLANTS; SINGLE-BLIND METHOD; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037499955     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000066647.77902.0B     Document Type: Article

References (22)

1. Soll DB. Evolution and current concepts in the surgical treatment of the anophthalmic orbit. Ophthal Plast Reconstr Surg. 1986;2: 163-71.
2. Gougelmann HP. The evolution of the ocular motility implant. In: Shannon GM, Connelly FJ, eds. Oculoplastic Surgery and Prosthetics. Boston: Little Brown; 1970:689-711.
3. Perry AC. Integrated orbital implants. Adv Ophthal Plast Reconstr Surg. 1990;8:75-81.
4. Remulla HD, Rubin PA, Shore JW, et al. Complications of porous spherical orbital implants. Ophthalmology 1995;102:586-93.
5. Rubin PA, Popham JK, Bilyk JR, et al. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg. 1994;10:96-103.
6. Nunnery WR, Heinz JW, Bonnie JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg. 1993;9:96-104.
7. Perry AC. Advances in enucleation. Ophthalmol Clin North Am. 1991;4:173-82.
8. Shields CL, Shields JA, Eagle RC Jr, et al. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol. 1991;111: 363-6.
9. Vestreicher JH. Treatment of exposed coral implant after failed scleral patch graft. Ophthal Plast Reconstr Surg. 1984;10:110-3.
10. Gayre GS, Lipham W, Dutton JJ. A comparison of rates of fibrovascular ingrowth in wrapped versus unwrapped hydroxyapatite spheres in rabbit model. Ophth Plast Reconstr Surg. 2002;18: 275-79.
11. Custer PL, Trinkaus KM, Fornoff J. Comparative motility of hydroxyapatite and alloplastic enucleation implants. Ophthalmology. 1999;106:513-6.
12. Demer JL, Miler JM, Poukens V, et al. Evidence for fibromuscular pulleys of the recti extraocular muscles. Invest Ophthalmol Vis Sci. 1995;36:1125-36.
13. Koornneef L. New insights into the human orbital connective tissue: result of a new anatomical approach. Arch Ophthalmol. 1977;95:1269-73.
14. Koornneef L. Orbital septa: anatomy and function. Ophthalmology 1979;86:876-80.
15. Shields CL, Shields JA, De Potter P, et al. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol. 1994;78:702-6.
16. De Potter P. Use of the hydroxyapatite implant in the pediatric population. Arch Ophthalmol. 1994;112:208-12.
17. Lang CJ, Heckmann JG, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci. 1998;160:128-39.
18. Cantrill HL, Henry K, Jackson B, et al. Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology. 1988;95: 1458-62.
19. Seiff SR, Chang JS Jr, Hurt MH, et al. Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera. Am J Ophthalmol. 1994;118:528-30.
20. Kaltreider SA, Newman SA. Prevention and management of complications associated with the hydroxyapatite orbital implant. Ophthal Plast Reconstr Surg. 1996;12:18-31.
21. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol. 1992; 13:669-73.
22. Long JA, Tann TM, Girkin CA. Evisceration: a new technique of trans-scleral implant placement. Ophthal Plast Reconstr Surg. 2000;16:322-5.